Medulloblastoma (MB) is the most common malignant brain tumour in children. This project is looking at a protein called p73, which plays a central role in the development of the central nervous system and in metabolism. We hope that this protein will help us to identify new ways of treating MB that are more effective and have fewer side effects than surgery and radio/chemotherapy.
This research project on medulloblastoma has been successfully completed. Your donations allow us to fund ground-breaking research that can improve treatments given to children with cancer. Thank you. Your help allows us to continue to find ways to drive up the chances of survival for children with cancer and reduce the toxic side effects that can affect the rest of their lives.
Metabolic analysis of the tumour suppressor protein p73 in medulloblastoma
Queen Mary University of London
London E1 2AT
1 September 2014